Back to OSAIC HOLDINGS, INC. OSAIC HOLDINGS, INC.

BCLIBCLI
5 quarters

Position history for OSAIC HOLDINGS, INC.OSAIC HOLDINGS, INC.'s holdings in BrainStorm Cell Therapeutics In

No. Osaic exited its BCLI (BrainStorm Cell Therapeutics in) position in Q4 2025. Its Q3 2025 13F listed 1,785 shares worth $1,351. Osaic first reported BCLI in Q4 2024 and held it in 4 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$4,344

Total Shares Change

-1,915

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$0.56
0
2025-Q3
Unchanged
1,785
0.0%
$1,3510.0%$0.70
0
2025-Q2
Increased
1,785
+3.8%
$1,9960.0%$1.06
8
2025-Q1
Decreased
1,719
-10.2%
$2,1640.0%$1.19
0
2024-Q4
New
1,915
-
$4,3440.0%$2.37
22

Other major holders of BCLI: VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used